Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00300443 · ClinicalTrials.gov registry record · Phase 2
Safety and Efficacy Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension
A Phase 2 study, sponsored by Allergan.
- Completed
- Registry status
- Phase 2
- Development phase
- 561
- Enrollment target
NCT00300443: Completed Phase 2 study, sponsored by Allergan.
NCT00300443 is a Phase 2 study that has completed, run by Allergan. The registered enrollment target is 561 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (322% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00300443, a Phase 2 study, has completed, sponsored by Allergan.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 561 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the safety and efficacy of bimatoprost in patients with glaucoma or ocular hypertension
Interventions
- DRUG bimatoprost
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 561 participants |
| Start Date | 2005-12 |
| Est. Completion | 2007-06 |
| Phase | Phase 2 |
What the finished NCT00300443 record still lists
NCT00300443 is an interventional study that assigns participants to a tested intervention. The registered 561 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (322% higher).
The record links to 0 conditions, and to 1 intervention - of which bimatoprost is the first listed.
NCT00300443 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00300443 about?
NCT00300443 is a clinical study titled "Safety and Efficacy Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension". The purpose of this study is to assess the safety and efficacy of bimatoprost in patients with glaucoma or ocular hypertension
What is the current status of trial NCT00300443?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 561 participants. The study started on 2005-12. Estimated completion is 2007-06.
What interventions are being tested in trial NCT00300443?
The interventions under investigation include: bimatoprost (DRUG).
Who is sponsoring clinical trial NCT00300443?
This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00300443's enrollment target sits among peer trials
561 60th of 2000 higher than 1,941 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07007065 · 561 participants · Phase 3
Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)
- NCT04661358 · 560 participants · Phase 3
Fenofibrate for Prevention of DR Worsening
- NCT05473871 · 560 participants · NA
Enhancing Capacity in Churches to Implement PA Programs
- NCT06001541 · 560 participants · NA
Web-based Program to Improve Self-management Among Veterans-caregiver Dyads
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia